1134 related articles for article (PubMed ID: 1312220)
1. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
Guy CT; Cardiff RD; Muller WJ
Mol Cell Biol; 1992 Mar; 12(3):954-61. PubMed ID: 1312220
[TBL] [Abstract][Full Text] [Related]
2. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.
Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ
Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074
[TBL] [Abstract][Full Text] [Related]
3. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
[TBL] [Abstract][Full Text] [Related]
4. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
[TBL] [Abstract][Full Text] [Related]
5. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
Trimble MS; Xin JH; Guy CT; Muller WJ; Hassell JA
Oncogene; 1993 Nov; 8(11):3037-42. PubMed ID: 7692372
[TBL] [Abstract][Full Text] [Related]
6. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
7. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541
[TBL] [Abstract][Full Text] [Related]
8. Mammary tumorigenesis and metastasis in transgenic mice.
Webster MA; Muller WJ
Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
[TBL] [Abstract][Full Text] [Related]
9. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.
Cully M; Shiu J; Piekorz RP; Muller WJ; Done SJ; Mak TW
Cancer Res; 2005 Nov; 65(22):10363-70. PubMed ID: 16288026
[TBL] [Abstract][Full Text] [Related]
10. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
[TBL] [Abstract][Full Text] [Related]
11. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.
Roussos ET; Wang Y; Wyckoff JB; Sellers RS; Wang W; Li J; Pollard JW; Gertler FB; Condeelis JS
Breast Cancer Res; 2010; 12(6):R101. PubMed ID: 21108830
[TBL] [Abstract][Full Text] [Related]
12. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
[TBL] [Abstract][Full Text] [Related]
13. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
[TBL] [Abstract][Full Text] [Related]
14. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
15. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.
Muller WJ; Sinn E; Pattengale PK; Wallace R; Leder P
Cell; 1988 Jul; 54(1):105-15. PubMed ID: 2898299
[TBL] [Abstract][Full Text] [Related]
16. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.
Hoenerhoff MJ; Shibata MA; Bode A; Green JE
Transgenic Res; 2011 Apr; 20(2):247-59. PubMed ID: 20549348
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.
Roselli S; Kahl RG; Copeland BT; Naylor MJ; Weidenhofer J; Muller WJ; Ashman LK
BMC Cancer; 2014 Jul; 14():509. PubMed ID: 25012362
[TBL] [Abstract][Full Text] [Related]
18. Transgenic Polyoma middle-T mice model premalignant mammary disease.
Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463
[TBL] [Abstract][Full Text] [Related]
19. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.
Green JE; Shibata MA; Yoshidome K; Liu ML; Jorcyk C; Anver MR; Wigginton J; Wiltrout R; Shibata E; Kaczmarczyk S; Wang W; Liu ZY; Calvo A; Couldrey C
Oncogene; 2000 Feb; 19(8):1020-7. PubMed ID: 10713685
[TBL] [Abstract][Full Text] [Related]
20. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.
Rauh MJ; Blackmore V; Andrechek ER; Tortorice CG; Daly R; Lai VK; Pawson T; Cardiff RD; Siegel PM; Muller WJ
Mol Cell Biol; 1999 Dec; 19(12):8169-79. PubMed ID: 10567542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]